Bloemen 2 , Lotte Haverman 1 , Selina Limmen 1 , Eugene A
You naturally want to eat less because your brain is receiving stronger Im satisfied signals
[25] [26] NICE recommends GLP-1 receptor agonists as second- or third-line therapy for type 2 diabetes when metformin and other oral agents have not achieved adequate control
For individuals with diabetes, a combined creatinine/cystatin C estimate of eGFR should be considered in settings where the creatinine-based eGFR may be unreliable for an individual (see Table 6) [21] [Grade D, Consensus]
They have also been shown to reduce the rates of major adverse cardiovascular events, comprising non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, in patients with type 2 diabetes mellitus
B.GoldbergerZ